vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and PEAPACK GLADSTONE FINANCIAL CORP (PGC). Click either name above to swap in a different company.
PEAPACK GLADSTONE FINANCIAL CORP is the larger business by last-quarter revenue ($78.2M vs $62.1M, roughly 1.3× Cytek Biosciences, Inc.). PEAPACK GLADSTONE FINANCIAL CORP runs the higher net margin — 15.5% vs -70.9%, a 86.5% gap on every dollar of revenue. On growth, PEAPACK GLADSTONE FINANCIAL CORP posted the faster year-over-year revenue change (26.5% vs 8.1%). PEAPACK GLADSTONE FINANCIAL CORP produced more free cash flow last quarter ($28.8M vs $-1.8M). Over the past eight quarters, PEAPACK GLADSTONE FINANCIAL CORP's revenue compounded faster (21.4% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Peapack Gladstone Financial Corp is a U.S.-based regional financial holding company that provides commercial and consumer banking, wealth management, private banking, lending solutions, and trust services, primarily serving individual and small-to-medium business clients across New Jersey and the surrounding U.S. Northeast region.
CTKB vs PGC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $78.2M |
| Net Profit | $-44.1M | $12.2M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 21.7% |
| Net Margin | -70.9% | 15.5% |
| Revenue YoY | 8.1% | 26.5% |
| Net Profit YoY | -557.1% | 31.6% |
| EPS (diluted) | — | $0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $78.2M | ||
| Q3 25 | $52.3M | $70.7M | ||
| Q2 25 | $45.6M | $69.7M | ||
| Q1 25 | $41.5M | $64.4M | ||
| Q4 24 | $57.5M | $61.8M | ||
| Q3 24 | $51.5M | $56.6M | ||
| Q2 24 | $46.6M | $56.6M | ||
| Q1 24 | $44.9M | $53.1M |
| Q4 25 | $-44.1M | $12.2M | ||
| Q3 25 | $-5.5M | $9.6M | ||
| Q2 25 | $-5.6M | $7.9M | ||
| Q1 25 | $-11.4M | $7.6M | ||
| Q4 24 | $9.6M | $9.2M | ||
| Q3 24 | $941.0K | $7.6M | ||
| Q2 24 | $-10.4M | $7.5M | ||
| Q1 24 | $-6.2M | $8.6M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 21.7% | ||
| Q3 25 | -17.6% | 19.2% | ||
| Q2 25 | -23.3% | 16.1% | ||
| Q1 25 | -36.1% | 16.2% | ||
| Q4 24 | 5.2% | 19.8% | ||
| Q3 24 | -8.2% | 19.0% | ||
| Q2 24 | -18.3% | 16.9% | ||
| Q1 24 | -23.9% | 23.4% |
| Q4 25 | -70.9% | 15.5% | ||
| Q3 25 | -10.5% | 13.6% | ||
| Q2 25 | -12.2% | 11.4% | ||
| Q1 25 | -27.5% | 11.8% | ||
| Q4 24 | 16.8% | 14.9% | ||
| Q3 24 | 1.8% | 13.4% | ||
| Q2 24 | -22.4% | 13.3% | ||
| Q1 24 | -13.8% | 16.3% |
| Q4 25 | — | $0.68 | ||
| Q3 25 | — | $0.54 | ||
| Q2 25 | — | $0.45 | ||
| Q1 25 | — | $0.43 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | — | $0.43 | ||
| Q2 24 | — | $0.42 | ||
| Q1 24 | — | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $658.2M |
| Total Assets | $461.5M | $7.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
| Q4 25 | $341.7M | $658.2M | ||
| Q3 25 | $378.6M | $642.5M | ||
| Q2 25 | $377.6M | $629.8M | ||
| Q1 25 | $379.6M | $621.9M | ||
| Q4 24 | $395.7M | $605.8M | ||
| Q3 24 | $385.5M | $607.6M | ||
| Q2 24 | $389.1M | $588.3M | ||
| Q1 24 | $392.6M | $582.4M |
| Q4 25 | $461.5M | $7.5B | ||
| Q3 25 | $494.9M | $7.4B | ||
| Q2 25 | $493.3M | $7.2B | ||
| Q1 25 | $482.6M | $7.1B | ||
| Q4 24 | $499.5M | $7.0B | ||
| Q3 24 | $491.2M | $6.8B | ||
| Q2 24 | $483.7M | $6.5B | ||
| Q1 24 | $492.1M | $6.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $43.1M |
| Free Cash FlowOCF − Capex | $-1.8M | $28.8M |
| FCF MarginFCF / Revenue | -2.9% | 36.8% |
| Capex IntensityCapex / Revenue | 1.6% | 18.3% |
| Cash ConversionOCF / Net Profit | — | 3.55× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $61.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $43.1M | ||
| Q3 25 | $-3.9M | $36.2M | ||
| Q2 25 | $108.0K | $15.9M | ||
| Q1 25 | $-125.0K | $-7.9M | ||
| Q4 24 | $2.0M | $71.1M | ||
| Q3 24 | $13.2M | $24.7M | ||
| Q2 24 | $6.2M | $852.0K | ||
| Q1 24 | $4.0M | $19.1M |
| Q4 25 | $-1.8M | $28.8M | ||
| Q3 25 | $-4.6M | $34.0M | ||
| Q2 25 | $-1.5M | $9.9M | ||
| Q1 25 | $-974.0K | $-11.5M | ||
| Q4 24 | $1.1M | $63.0M | ||
| Q3 24 | $12.2M | $23.0M | ||
| Q2 24 | $5.2M | $-431.0K | ||
| Q1 24 | $3.4M | $18.0M |
| Q4 25 | -2.9% | 36.8% | ||
| Q3 25 | -8.7% | 48.1% | ||
| Q2 25 | -3.2% | 14.2% | ||
| Q1 25 | -2.3% | -17.8% | ||
| Q4 24 | 1.9% | 101.9% | ||
| Q3 24 | 23.7% | 40.6% | ||
| Q2 24 | 11.0% | -0.8% | ||
| Q1 24 | 7.6% | 33.9% |
| Q4 25 | 1.6% | 18.3% | ||
| Q3 25 | 1.3% | 3.1% | ||
| Q2 25 | 3.5% | 8.6% | ||
| Q1 25 | 2.0% | 5.6% | ||
| Q4 24 | 1.6% | 13.1% | ||
| Q3 24 | 2.0% | 3.0% | ||
| Q2 24 | 2.3% | 2.3% | ||
| Q1 24 | 1.3% | 2.1% |
| Q4 25 | — | 3.55× | ||
| Q3 25 | — | 3.76× | ||
| Q2 25 | — | 2.01× | ||
| Q1 25 | — | -1.04× | ||
| Q4 24 | 0.21× | 7.70× | ||
| Q3 24 | 14.05× | 3.25× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 2.21× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PGC
| Banking Segment | $61.4M | 79% |
| Wealth Management Division | $13.9M | 18% |
| Other | $2.9M | 4% |
